![]() |
|
|
Forward to a colleague |
||
Access Full Stories Baxter International has suspended the production of its blood-thinning drug heparin in multi-dose vials, following the deaths of four patients in the USA who were given the drug in high doses... Read Pfizer expands in inhaled drugs as Nektar cuts back Pfizer's announcement of plans to create a new €130m inhaled medicines unit at its facility in Amboise, France suggests that the firm is still intent on investing in inhalation technology, despite its disappointment... Read Tablet demand helps lift FMC BioPolymer in Q4 Continued strong global demand for oral tablet formulations helped drive a robust performance by FMC BioPolymer in the fourth quarter of 2007... Read Smart pillbox takes on TB In the fight against tuberculosis in Africa a group from Massachusetts Institute of Technology has invented a smart electromechanical pill box designed to help patients comply with their treatment... Read Contract manufacturing news in brief DSM, Althea, Laureate Pharma, Albemarle and Patheon have all recently announced new contract manufacturing news... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() Valois Pharma: Expert in Nasal & Pulmonary Drug Delivery Valois Pharma is a world-renowned expert in the design, development, manufacture and marketing of proprietary, non-invasive Drug Delivery Devices. Valois Pharma offers the largest range of Product & Services ranging from off-the shelf product to tailor-made spray and aerosol... Click Here | ||||||||||||||||||
|
Related Industry News SfN outlines strategies to counter animal extremists The threat of intimidation, harrassment and violence by animal extremist goups has prompted new recommendations detailing measures scientific institutions can take to protect laboratory researchers... Read EC 'unlikely to support ban on primate testing' The European Commission is unlikely to support an outright ban on the use of non-human primates in research, but has just published a new document which indicates that significant changes to current legislation... Read Beckman Coulter sees earnings drop in Q4 Beckman Coulter saw its fourth quarter earnings held back by acquisition costs that overshadowed a near 11 per cent hike in revenues... Read Tufts heralds outsourcing as the way of the future The trend towards outsourcing and outside partnering to improve drug development is tipped to continue, with the strategy being heralded as the way of the future in new research produced by the Tufts Center for... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||